CYBA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.688400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.664600E-01
Normal-vs-Stage2
9.889200E-01
Normal-vs-Stage3
9.390400E-01
Normal-vs-Stage4
3.273800E-01
Stage1-vs-Stage2
2.199200E-01
Stage1-vs-Stage3
6.371200E-01
Stage1-vs-Stage4
9.265400E-01
Stage2-vs-Stage3
8.828000E-01
Stage2-vs-Stage4
2.557600E-01
Stage3-vs-Stage4
5.717400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.976200E-01
Normal-vs-AfricanAmerican
6.281400E-01
Normal-vs-Asian
3.275800E-01
Caucasian-vs-AfricanAmerican
7.751800E-01
Caucasian-vs-Asian
1.322460E-02
AfricanAmerican-vs-Asian
5.388300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.139800E-01
Normal-vs-Female
9.324800E-01
Male-vs-Female
5.186400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.158200E-01
Normal-vs-Age(41-60Yrs)
9.315400E-01
Normal-vs-Age(61-80Yrs)
8.170000E-01
Normal-vs-Age(81-100Yrs)
9.357400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.329400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.134800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.574200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.498800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.294000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.387000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.139000E-01
Normal-vs-Daily Drinker
8.746600E-01
Normal-vs-Weekly Drinker
6.429200E-01
Normal-vs-Occasional Drinker
9.201200E-01
Normal-vs-Social Drinker
9.383000E-01
Non Drinker-vs-Daily Drinker
8.602400E-01
Non Drinker-vs-Weekly Drinker
5.014800E-01
Non Drinker-vs-Occasional Drinker
6.632400E-01
Non Drinker-vs-Social Drinker
7.147000E-01
Daily Drinker-vs-Weekly Drinker
6.870800E-01
Daily Drinker-vs-Occasional Drinker
6.193000E-01
Daily Drinker-vs-Social Drinker
6.689800E-01
Weekly Drinker-vs-Occasional Drinker
3.827200E-01
Weekly Drinker-vs-Social Drinker
4.370200E-01
Occasional Drinker-vs-Social Drinker
9.780000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.722800E-01
Normal-vs-Grade 2
2.520600E-01
Normal-vs-Grade 3
2.413600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.958360E-03
Grade 1-vs-Grade 3
5.520800E-03
Grade 1-vs-Grade 4
8.722800E-01
Grade 2-vs-Grade 3
9.512600E-01
Grade 2-vs-Grade 4
2.520600E-01
Grade 3-vs-Grade 4
2.413600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.986200E-01
Normal-vs-NonDiabetic
9.668400E-01
Diabetic-vs-NonDiabetic
8.937800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.312200E-01
Normal-vs-NoPancreatitis
9.306800E-01
Pancreatitis-vs-NoPancreatitis
9.505900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.647200E-01
Normal-vs-N1
9.315200E-01
N0-vs-N1
6.861000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.208200E-01
Normal-vs-TP53-NonMutant
2.086000E-01
TP53-Mutant-vs-TP53-NonMutant
1.439760E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
